Melody Brown

614 total citations
8 papers, 539 citations indexed

About

Melody Brown is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Melody Brown has authored 8 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Melody Brown's work include Biochemical and Molecular Research (5 papers), Quinazolinone synthesis and applications (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Melody Brown is often cited by papers focused on Biochemical and Molecular Research (5 papers), Quinazolinone synthesis and applications (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Melody Brown collaborates with scholars based in United Kingdom and France. Melody Brown's co-authors include Rosemary Kimbell, A.L. Jackman, William Gibson, A H Calvert, Ann L. Jackman, G. Wynne Aherne, Lloyd R. Kèlland, William Gibson, Anthea Hardcastle and J. Michael Wardleworth and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and Advances in experimental medicine and biology.

In The Last Decade

Melody Brown

8 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melody Brown United Kingdom 7 315 292 93 87 82 8 539
A L Jackman United Kingdom 9 302 1.0× 230 0.8× 71 0.8× 78 0.9× 125 1.5× 12 515
A.L. Jackman United Kingdom 13 503 1.6× 513 1.8× 100 1.1× 150 1.7× 140 1.7× 24 842
Jesse R. Bewley United States 7 294 0.9× 337 1.2× 93 1.0× 328 3.8× 90 1.1× 9 734
Susan B. Gates United States 9 348 1.1× 387 1.3× 100 1.1× 347 4.0× 102 1.2× 11 837
Lynn S. Gossett United States 10 475 1.5× 381 1.3× 148 1.6× 338 3.9× 142 1.7× 13 943
G. A. Taylor United Kingdom 13 211 0.7× 157 0.5× 60 0.6× 79 0.9× 44 0.5× 20 422
Katherine A. Shackelford United States 8 303 1.0× 363 1.2× 31 0.3× 353 4.1× 104 1.3× 10 741
Kamran Gharehbaghi Austria 13 328 1.0× 127 0.4× 64 0.7× 103 1.2× 53 0.6× 25 675
Elizabeth A. Rayl United States 4 280 0.9× 272 0.9× 19 0.2× 285 3.3× 67 0.8× 4 615
Lillian L. Habeck United States 10 421 1.3× 461 1.6× 36 0.4× 467 5.4× 131 1.6× 16 983

Countries citing papers authored by Melody Brown

Since Specialization
Citations

This map shows the geographic impact of Melody Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melody Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melody Brown more than expected).

Fields of papers citing papers by Melody Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melody Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melody Brown. The network helps show where Melody Brown may publish in the future.

Co-authorship network of co-authors of Melody Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Melody Brown. A scholar is included among the top collaborators of Melody Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melody Brown. Melody Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marsham, Peter R., J. Michael Wardleworth, Laurent Hennequin, et al.. (1999). Design and Synthesis of Potent Non-Polyglutamatable Quinazoline Antifolate Thymidylate Synthase Inhibitors. Journal of Medicinal Chemistry. 42(19). 3809–3820. 39 indexed citations
2.
Jackman, Ann L., Rosemary Kimbell, Melody Brown, et al.. (1995). The Antitumour Activity of ZD9331, a Non-Polyglutamatable Quinazoline Thymidylate Synthase Inhibitor. Advances in experimental medicine and biology. 370. 185–188. 21 indexed citations
3.
Jackman, A.L., Lloyd R. Kèlland, Rosemary Kimbell, et al.. (1995). Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. British Journal of Cancer. 71(5). 914–924. 88 indexed citations
4.
Jackman, Ann L., Rosemary Kimbell, Melody Brown, et al.. (1995). Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation.. PubMed. 10(7). 573–89. 7 indexed citations
5.
HUGHES, L. R., Anthony M. Slater, T C Stephens, et al.. (1993). Substituted-2-Desamino-2-Methyl-Quinazolinones. A Series of Novel Antitumour Agents. Advances in experimental medicine and biology. 338. 585–588. 6 indexed citations
6.
Jackman, Ann L., et al.. (1993). The Role of the Reduced-Folate Carrier and Metabolism to Intracellular Polyglutamates for the Activity of ICI D1694. Advances in experimental medicine and biology. 339. 265–276. 38 indexed citations
7.
Jackman, A.L., et al.. (1991). ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.. PubMed. 51(20). 5579–86. 322 indexed citations
8.
Kaufman, Nathan, Haim I. Bicher, Fred W. Hetzel, & Melody Brown. (1981). A system for determining the pharmacology of indirect radiation sensitizer drugs on multicellular spheroids.. PubMed. 4(2). 199–204. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026